At the beginning of 2008 there were more than 400 clinical trials underway to understand and treat Alzheimer's disease. Alzheimer's vaccine ACC-001 was just on the second stage when there appeared side effects.
The companies responsible for Phase II trials - Wyeth and Elan Corp - had to suspend dosing when they learned that a patient developed unexplained skin lesions.
The following decision was taken after discussions with Food and Drug Administration. The suspension is due to expand also outside of the U.S.
This situation has a precedent when in 2002 the work at Alzheimer's drug, known as AN-1792, was suspended due to reports of brain inflammation.
Actually this temporary difficulty can’t shade the studies of another Alzheimer's drug - AAB-001 - believed to have potential to improve cognitive function in Alzheimer's patients. And the expected minor negative share price response may be even effective to draw attention to AAB-001.
The behavior of the Russian inspector satellite, which was launched in the autumn of 2017, puzzles military officials in the United States
When the bill was submitted to Congress on August 2, the reason for imposing the new sanctions on Russia was based on Russia's alleged interference in the US presidential election in 2016, but then something clicked
Vladimir Putin is planning to attend the wedding ceremony of Austria's Foreign Minister Karin Kneissl on the way to Berlin